featured
Black Patients Still Underrepresented in Trials for New Drug Approvals
No improvement seen in representation of Black patients after implementation of a 2015 FDA action plan to improve diversity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.